.
MergerLinks Header Logo

New Deal


Cover Image ALDER BIOPHARMACEUTICALS
ALDER BIOPHARMACEUTICALS

ALDER BIOPHARMACEUTICALS

HQ - Stockholm

Summary


Alder Biopharmaceuticals provides pharmaceutical products and services. The Company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

Deals Overview

Total Deals1
Valued Deals1
Total Value£1,559M
Avg. Deal Size£1,559M

Investment Criteria

Target Equity CheckUSD 5-20m
Fund CurrencyEUR
Total funds raised$100m-500m

Investment Strategies

Buyout

Growth


Geographic Preferences

Europe

Denmark

Faroe Islands

Finland

Iceland

Norway

Sweden


Industry Preferences

Energy and Power

Renewable Energy

Technology Hardware and Equipment

Commercial Services

Technology

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US